1. Tomic R,
Podgaetz E,
Andrade RS,
et al.
Cryotechnology in diagnosing and treating lung diseases.
J Bronchology Interv Pulmonol 2015; 22:76-84
2. Abtin FA,
Eradat JE,
Gutierrez AJ,
et al. Radiofrequency ablation of lung tumors: imaging features of the post ablation zone. Radiographics 2012; 32:947-969
3. Davidson RS,
Nwogu CE,
Brentjens MJ,
et al. The surgical management of pulmonary metastasis: current concepts. Surg Oncol 2001; 10:35-42
4. Yamauchi Y,
Izumi Y,
Kawamura M,
et al.
Percutaneous cryoablation of pulmonary metastases from colorectal cancer.
PLoS One 2011; 6:e27086
5. Macbeth F, Russell C,
Treasure T.
Cryotherapy for lung metastases: a justifiable procedure? J Thorac Oncol 2015; 10:e120-e121.
6. Kawamura M,
Izumi Y,
Tsukada N,
et al.
Percutaneous cryoablation of small pulmonary malignant tumors under computed tomographic guidance with local anesthesia for nonsurgical candidates.
J Thorac Cardiovasc Surg 2006; 131:1007-1013.
7. Bahn DK,
Lee F,
Badalament R,
et al.
Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002; 60:3-11
8. Lee FT,
Jr,
Mahvi DM,
Chosy SG,
et al.
Hepatic cryosurgery with intraoperative US guidance. Radiology 1997; 202:624-632.
9. Wang H,
Littrup PJ,
Duan Y,
et al.
Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures.
Radiology 2005; 235:289-298.
10. Inoue M,
Nakatsuka S,
Yashiro H,
et al.
Percutaneous cryoablation of lung tumors: feasibility and safety.
J Vasc Interv Radiol 2012; 23:295-302
11. Dupuy DE,
Zagoria RJ,
Akerley W,
et al.
Percutaneous radiofrequency ablation of malignancies in the lung. AJR Am J Roentgenol 2000; 174:57-59.
12. Chaudhry A, Grechushkin V ,
Hoshmand M,
et al.
Characteristic CT findings after percutaneous cryoablation treatment of malignant lung nodules.
Medicine (Baltimore) 2015; 94:e16
13. Lu NH,
Hung CM,
Liu KY,
et al.
Diagnosed chest lesion on diffusion-weighted magnetic resonance images using apparent diffusion coefficients.
J Xray Sci Technol 2016; 24:133-143
14. Souza CA.
MRI of the chest: review of imaging strategies.
Radiol Bras 2015; 48:V-VI
15. Onishi H,
Matsushita M,
Murakami T,
et al.
MR appearances of radiofrequency thermal ablation region: histopathologic correlation with dog liver models and an autopsy case.
Acad Radiol 2004; 11:1180-1189
16. Liu S,
Ren R,
Liu M,
et al.
MR imaging-guided percutaneous cryotherapy for lung tumors: initial experience.
J Vasc Interv Radiol 2014; 25:1456-1462.
17. Goldberg SN,
Gazelle GS,
Compton CC,
et al. Radiofrequency tissue ablation in the rabbit lung: efficacy and complications. Acad Radiol 1995; 2:776-784
18. Rong G,
Bai W,
Dong Z,
et al.
Long-term outcomes of percutaneous cryoablation for patients with hepatocellular carcinoma within Milan criteria.
PLoS One 2015; 10:e0123065.
19. Niu LZ,
Li JL,
Xu KC.
Percutaneous cryoablation for liver cancer.
J Clin Transl Hepatol 2014; 2:182-188
20. Heye T,
Sommer G,
Miedinger D,
et al.
Ultrafast 3D balanced steady-state free precession MRI of the lung: assessment of anatomic details in comparison to low-dose CT.
J Magn Reson Imaging 2015; 42:602-609.
21. Park HJ,
Kim SH,
Jang KM,
etal.
Added value of diffusion-weighted MRI for evaluating viable tumor of hepatocellular carcinomas treated with radiotherapy in patients with chronic liver disease.
AJR Am J Roentgenol 2014; 202:92-101.
22. Alberg AJ,
Samet JM. Epidemiology of lung cancer. Chest 2003; 123(1 suppl):21S.
23. Jemal A,
Bray F,
Center MM,
et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69-90.
24. Jones GC,
Kehrer JD,
Kahn J,
et al.
Primary treatment options for high-risk/medically inoperable early stage NSCLC patients.
Clin Lung Cancer 2015; 16:413-430
25. Zemlyak A,
Moore WH,
Bilfinger TV. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll of Surg 2010; 211:68-72
26. de Baere T,
Tselikas L,
Woodrum D,
et al.
Evaluating cryoablation of metastatic lung tumors in patients--safety and efficacy: The ECLIPSE Trial--interim analysis at 1 year.
J Thorac Oncol 2015; 10:1468-1474
27. Romaneehsen B,
Anders M,
Röhrl B,
et al.
Cryotherapy of malignant tumors: studies with MRI in an animal experiment and comparison with morphological changes.
Rofo 2001; 173:632-638.
28. Chu KF,
Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat Rev Cancer 2014; 14:199-208
29. Suh RD,
Wallace AB,
Sheehan RE,
et al. Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation-preliminary results.
Radiology 2003; 229:821-829
30. Ito N,
Nakatsuka S,
Inoue M,
et al. Computed tomographic appearance of lung tumors treated with percutaneous cryoablation. J Vasc Interv Radiol 2012; 23:1043-1052
31. Koyama H,
Ohno Y,
Seki S,
et al.
Value of diffusion-weighted MR imaging using various parameters for assessment and characterization of solitary pulmonary nodules.
Eur J Radiol 2015; 84:509-515.
32. Ludwig JM,
Camacho JC,
Kokabi N,
et al.
The role of diffusion-weighted imaging (DWI) in locoregional therapy outcome prediction and response assessment for hepatocellular carcinoma (HCC): the new era of functional imaging biomarkers.
Diagnostics (Basel) 2015; 5: 546-563.